Cisco Releases New Developer Capabilities Across Its Intent-Based Networking Platform
ORLANDO, Fla., June 12, 2018 (GLOBE NEWSWIRE) -- CISCO LIVE - Cisco today announced that it has released new developer capabilities across its intent-based networking platform. These advancements underscore Cisco's continued progress in delivering an open, programmable platform that spans the entire network, from campus to data center, branch to edge. By providing an open network, Cisco is empowering 500,000 developers, 60,000 partners and three million network engineers to innovate upon the platform.
Intent-based networking represents a fundamental shift in the way networks are built and managed. Moving away from the manual, time-intensive methods by which networks are traditionally managed, these modern networks capture business intent and translate it into network policies. These policies are then automatically activated across the entire infrastructure, with the assurance that the business intent was delivered as planned.
"Intent-based networking represents the next generation of open, IP-based systems that we've seen can change the actual fabric of society," said David Goeckeler, executive vice president and general manager of Cisco's Networking and Security Business. "Cisco is building an open architecture that will power an ecosystem to accelerate intent-based networking innovation. Already, our customers and partners are creating value from their networks in ways they thought weren't possible as recently as one year ago."
Announcing the DNA Center platform
Today, Cisco is releasing new developer tools and open APIs into Cisco DNA(TM) Center - the command and control center for campus, branch and edge intent-based networks. DNA Center turns the network from a combination of hardware devices into a single system. With the availability of network-wide APIs, Cisco now allows developers to easily program this system, tapping into all of the analytics and insight the network can provide.
With a rich API catalog, DNA Center allows customers to protect and inform their business like never before.
Elevating network intelligence into business operations: DNA Center helps enable developers to program the network as a single system through intent-based APIs. Now, developers can more easily create a new generation of network-aware applications, and partners can integrate the network into business processes.
Streamline IT processes across functions: DNA Center helps enable network IT administrators to exchange information to automate processes across IT systems through software adapters. Now, IT can move resources from operation to innovation.
Managing multi-vendor networks: DNA Center gives developers and partners the flexibility to support multi-vendor networks via a software developer kit (SDK). This allows customers to simplify the complexity of heterogeneous networks and manage them consistently, as a single system.
Already, 15 Cisco partners have built innovative solutions on the DNA Center platform and are demonstrating them at Cisco Live.
Announcing the largest developer community for intent-based networking
Cisco is also announcing that its developer community, DevNet, has surpassed 500,000 members. In building this large and active community, Cisco has introduced a new source of innovation as the network becomes increasingly programmable.
Today, Cisco is announcing three new developer initiatives to fuel its innovation ecosystem:
DevNet Ecosystem Exchange makes it easy to find and share an application or solution built for Cisco platforms. Business leaders and developers alike can use this online portal to discover partner solutions that span all Cisco platforms and products. It contains over 1,300 solutions.
DevNet Code Exchange gives developers a place to access and share software to quickly build next-generation applications and workflow integrations. A curated list of sample code, adaptors, tools, and SDKs is available on GitHub and written by Cisco and the DevNet community. Code Exchange spans Cisco's entire portfolio and is organized according to Cisco platform and product areas.
- DevNet DNA Developer Center is a one-stop-shop for developers to build applications and integrations on the DNA Center platform. It provides comprehensive resources, capabilities, use cases and learning materials for developers.
Availability, Services and Support
- The new DNA Center capabilities are scheduled to be available during the summer of 2018. Customers can purchase these new capabilities from Cisco and its partners via existing subscription offers.
- DevNet's Ecosystem Exchange, Code Exchange, and DNA Developer Center are available now.
- Cisco and its partners offer a full lifecycle of services to help customers streamline the journey to truly intent-based networks.
- Executive Blog: Why We're Making Intent-Based Networking Into a Platform, By Scott Harrell
- Executive Blog: Imagine the Possibilities, Blog by Nirav Sheth
- Executive Blog: Cisco DevNet Hits 500,000 Members, Gain Critical Mass, by Susie Wee
- Feature Story: The Network is Open for Business
- Video: Perspectives on the Power of an Open Platform
Cisco (NASDAQ:CSCO) is the worldwide technology leader that has been making the Internet work since 1984. Our people, products, and partners help society securely connect and seize tomorrow's digital opportunity today. Discover more at newsroom.cisco.com and follow us on Twitter at @Cisco.
Cisco, the Cisco logo, Cisco and Cisco IOS Systems are registered trademarks or trademarks of Cisco Systems, Inc. and/or its affiliates in the United States and certain other countries. All other trademarks mentioned in this document are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company. This document is Cisco Public Information.
RSS Feed for Cisco: http://newsroom.cisco.com/rss-feeds
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cisco via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
WillScot Announces Closing of Warrant Exchange Offer11.12.2018 22:05 | Pressemelding
BALTIMORE, Dec. 11, 2018 (GLOBE NEWSWIRE) -- WillScot Corporation (“WillScot”) (NASDAQ: WSC), the specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced the closing of its previously announced exchange offer (the “Exchange Offer”) relating to certain outstanding warrants issued in 2015 (the “Warrants”). Under the terms of the Exchange Offer, each Warrant holder had the opportunity to receive 0.18182 shares of WillScot Class A Common Stock, par value $0.0001 per share (“Common Stock”), for each Warrant tendered by the holder and exchanged pursuant to the Exchange Offer. As of the closing of the Exchange Offer on December 11, 2018, 45,131,827 outstanding Warrants were properly tendered and not withdrawn in the Exchange Offer. 45,031,827 of the Warrants tendered were public warrants, representing approximately 89% of the public warrants, and approximately 100,000 Warrants tendered were private warrant
DoubleVerify and InMobi Unite to Combat Mobile App Fraud11.12.2018 18:02 | Pressemelding
Partnership brings mobile app fraud prevention to advertisers globally NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- DoubleVerify ("DV"), the leading independent provider of marketing measurement software and analytics, today announced a partnership with InMobi, a global provider of enterprise platforms for marketers. As part of the partnership, DoubleVerify will provide always-on fraud filtering and measurement for mobile in-app advertising campaigns across the InMobi Exchange globally. The integration with InMobi covers pre-bid targeting for all InMobi Exchange impressions within the leading mobile in-app platform, as well as monitoring of post-bid fraud activity, such as spoofing – enabling InMobi to continuously refine the quality of its mobile ad inventory. “DV’s partnership with InMobi demonstrates our commitment to provide consistent, comprehensive quality coverage for global brand advertisers,” said Matt McLaughlin, COO at DoubleVerify. “With ad spend increasingly concentrated in
Claroty Announces Major Enhancements to Market-Leading Industrial Cybersecurity Platform11.12.2018 15:00 | Pressemelding
Groundbreaking multispectral data acquisition and network segmentation capabilities provide deeper OT network visibility and reduce risk for industrial enterprises and critical infrastructure providers NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Claroty, the leader in operational technology (OT) network protection, today announced several significant enhancements to its award-winning Continuous Threat Detection product and technology integrations with several leading industrial automation, network infrastructure and cybersecurity providers. Already the industry’s most complete industrial control systems (ICS) cybersecurity platform, this release incorporates new functionality to provide even more “extreme” visibility into ICS networks and help industrial enterprises decrease the risk of a cyberattack. The latest release of Claroty Continuous Threat Detection provides a large number of significant enhancements including: Virtual Zones and OT Network Segmentation – an innovative approach
INN Launches Battery Metals Channel11.12.2018 15:00 | Pressemelding
The new battery metals channel is designed to educate investors with original content and expert insight on the growing battery metals industry. VANCOUVER, British Columbia, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Investing News Network (INN) announces the launch of its battery metals channel. Responding to the growth and evolution of the battery metals market, this channel will host news, educational content and expert opinions on the lithium, cobalt, graphite, vanadium and manganese market segments. “INN has been a trusted source of information on the lithium, cobalt, graphite, vanadium and manganese markets for nearly a decade, and is excited to bring these sectors together under the battery metals umbrella,” said Nick Smith, CEO and publisher at INN. “Through connections with experts, our leading team of experienced writers creates original, insightful content on battery metals. INN educates investors in the industry by providing information they may never have access to on their own,” S
Galimedix Therapeutics Appoints Industry Veteran, Hermann Russ, M.D., Ph.D., Chief Scientific Officer11.12.2018 14:30 | Pressemelding
KENSINGTON, Md. and SHORASHIM, Israel, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Galimedix Therapeutics, which is developing new solutions for ophthalmic and neurodegenerative diseases, announced the appointment of Hermann Russ, M.D., Ph.D., as its chief scientific officer, effective December 1, 2018. Dr. Russ invented the use of the company’s lead molecule GAL-101/MRZ-99030 for the treatment of degenerative diseases of the retina, including glaucoma and dry macular degeneration. He is also co-inventor of the so-called “trigger effect” of GAL-101/MRZ-99030 and GAL-102/MRZ 14042, which is a unique reverse prion-like self-propagation mechanism of action important for the company’s eye drop and oral treatment regimens. “We are gratified that Dr. Russ is joining the Galimedix management team, as his knowledge in the field, as well as intimate experience with the compound, have already proven instrumental in the development of our company to date,” commented Andrew Pearlman, Ph.D., CEO of Galimedix
Farmako: Cannabis distributor to become gateway to Europe11.12.2018 10:00 | Pressemelding
Company is first to apply for a licence in the United Kingdom AAA-Team pushes to become gateway to Europe Company first to apply for distribution licences in UK Support of Canadian LP to obtain EU-GMP Focus on research and development FRANKFURT, Germany, Dec. 11, 2018 (GLOBE NEWSWIRE) -- The Frankfurt-based pharmaceutical company Farmako is a research-based pharmaceutical company that distributes medical cannabis. The company is active in all European markets that have created a legal basis for cannabinoid therapies. It is the first company for medical Cannabis pursue distribution licences in multiple European countries. Fort hat, it will rely on EU-GMP certified suppliers. The German market for medical cannabis is estimated at 19.1 million euros in 2018 and at 200 million Euros by 2019. For 2028, experts expect a market volume for medical cannabis of 7.8 billion euros in Germany, an increase by a factor of 400. The number of patients for cannabinoid therapies in Germany has grown from
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom